Larkin Cristina 4
4 · Spero Therapeutics, Inc. · Filed Aug 30, 2021
Insider Transaction Report
Form 4
Larkin Cristina
Chief Operating Officer
Transactions
- Award
Common Stock
2021-08-26+24,067→ 25,567 total
Footnotes (1)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 26, 2022, subject to the Reporting Person's continued service through the applicable vesting date.